Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer

Archive ouverte

Natuzzi, Marco | Grange, Coralie | Gréa, Thomas | Brichart, Thomas | Aigle, Axel | Bechet, Denise | Hautefeuille, Benoit | Thomas, Eloise | Ayoub, Jean-Yves | Bonnet-Garin, Jeanne-Marie | Louzier, Vanessa | Allaouchiche, Bernard | Couturier, Aymeric | Montembault, Alexandra | de Oliveira, Paula Nunes | David, Laurent | Lux, François | Tillement, Olivier

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract In this article, we report the conception and the use of dialysis-based medical device for the extraction of metals. The medical device is obtained by addition in the dialysate of a functionalized chitosan that can chelate endogenous metals like iron or copper. This water-soluble functionalized chitosan is obtained after controlled reacetylation and grafting of DOTAGA. Due to the high mass of chitosan, the polymer cannot cross through the membrane and the metals are trapped in the dialysate during hemodialysis. Copper extraction has been evaluated in vitro using an hemodialysis protocol. Feasibility study has been performed on healthy sheep showing no acute toxicity througout the entire dialysis procedure and first insights of metallic extraction even on healthy animals.

Suggestions

Du même auteur

Biodegradable hydrogel for sustained release of therapeutic peptide

Archive ouverte | Rosson, Elise | CCSD

International audience

Malignant hyperthermia observed during the establishment of a new porcine model of acute kidney injury induced by ischemia-reperfusion

Archive ouverte | Guilpin, Axel | CCSD

International audience

Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

Archive ouverte | Gréa, Thomas | CCSD

International audience. Abstract Subcutaneous (SC) administration of monoclonal antibodies (mAbs) is a proven strategy for improving therapeutic outcomes and patient compliance. The current FDA‐/EMA‐approved enzymat...

Chargement des enrichissements...